Skip to main content
VCbacked
Log inGet Started

Shoreline Biosciences

La Jolla, United States

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

$140.0M raised
Nov 2021
Series B
BiotechnologyHealth CareLife ScienceMedical

Top Investors

Janus Henderson InvestorsCormorant Asset ManagementCommodore CapitalBeiGeneIrving Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Shoreline Biosciences

How much funding has Shoreline Biosciences raised?
Shoreline Biosciences has raised $140.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Who are Shoreline Biosciences's investors?
Shoreline Biosciences's investors include Janus Henderson Investors, Cormorant Asset Management, Commodore Capital, BeiGene, Irving Investors.
Where is Shoreline Biosciences headquartered?
Shoreline Biosciences is headquartered in La Jolla, United States.
What does Shoreline Biosciences do?
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.
What stage is Shoreline Biosciences at?
Shoreline Biosciences is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Shoreline Biosciences — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/shoreline-biosciences. Accessed July 2, 2026.
APA
VCBacked. (2021). Shoreline Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/shoreline-biosciences
Wikipedia (cite web)
{{cite web |title=Shoreline Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/shoreline-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K